Not logged in...
About USC Norris
FAQ - Trials
Contact Us - Trials
Support USC Norris
» Contact Us
If you are a patient, please contact
Keck Medical Center of USC
A Randomized, Open-Label, Phase III Study of Nivolumab (BMS-936558) vs. Everolimus in Subjects with Advanced or Metastatic Clear Cell Renal Cell Carcinoma Who Have Received Prior Anti-Angiogenic Therapy.
Closed to Accrual with Ongoing Follow-up
Chemotherapy: Systemic, Immunotherapy
Defintions of terms and FAQ about clinical trials.
David Quinn, M.D.
Other Trial Staff:
Lagrimas Ilagan, D.M., Roberto Tejada, D.M., Taison Tran, Coordinator, Taison Tran, R.N., Yvette Viverette, R.N., Torsten Fischer, R.N.
to see study documents.
Click here to see trial eligibility criteria and further details at ClinicalTrials.gov
For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or
To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3111.